CYDY Company Profile

CYDY Time & Sales

CYDY Recent News

CYDY Filings

CYDY Financials

CYDY Buy Rating

sunray3

07/24/2025 1:58:43 PM

Well said. Free (2)

Buddyboy20

07/24/2025 10:47:19 AM

Apparently, Colorectal Cancer (CRC) (19)

PennySlayer

07/24/2025 10:34:58 AM

They also have not signed an office (1)

hoops

07/24/2025 10:11:22 AM

Sorry. Must be a glitch on Schwab. (1)

hoops

07/24/2025 9:34:26 AM

The manipulation gets ridiculous. 18K (1)

Hyperbolic

07/24/2025 9:08:36 AM

Would you care to (2)

pnwtri

07/24/2025 8:22:16 AM

Pestell is going to bring this thing (4)

HHIGambler

07/24/2025 6:05:46 AM

I sent the link to the admin and (2)

ohm20

07/24/2025 4:06:45 AM

What does this mean? That he needs a (5)

skezan

07/23/2025 11:31:55 PM

CNPV fun facts: FAQs: Commissioners (8)

HouseofCards

07/23/2025 9:39:53 PM

We can still sell like 250M shares if (2)

mfglola

07/23/2025 9:11:09 PM

So FDA is now accepting applications (8)

biloxiblues

07/23/2025 8:29:23 PM

We will be fine! (2)

sean007

07/23/2025 8:01:14 PM

Money is never out of (4)

Mr3Putt

07/23/2025 6:35:43 PM

Thoughts? Upwithstock IIRC has (5)

bucweey34

07/23/2025 6:08:28 PM

Question for those with more knowledge (1)

Buddyboy20

07/23/2025 5:50:30 PM

"I still vividly remember the sharp (8)

sean007

07/23/2025 5:43:23 PM

"Beneath the surface"...remains the (1)

KenChowder

07/23/2025 5:29:34 PM

Sherlock, companies who make tender (6)

sjacobs26

07/23/2025 4:41:02 PM

I could be off here, but considering (10)

sherlock57

07/23/2025 3:57:35 PM

Sunray--Imagine the response of the (18)

cardamine

07/23/2025 3:07:08 PM

Wiki even makes a separate section for (2)

cardamine

07/23/2025 2:53:12 PM

yeah there's been the proverbial "blood (1)

sunray3

07/23/2025 1:12:31 PM

Oh, I'm sure as I suspect you are that (7)

twinter11

07/23/2025 12:57:30 PM

"I don't pretend to know the motives (7)

sunray3

07/23/2025 12:07:51 PM

Now mind you, I don't pretend to know (3)

sunray3

07/23/2025 11:11:08 AM

Definitely BS, you're right...the MM (7)

Tprovo

07/23/2025 10:43:31 AM

Gap filled at .28 this AM and so did my (2)

Evil Rabbit

07/23/2025 10:03:41 AM

That premarket action was some BS. 11k (6)

dfwl28

07/23/2025 9:55:10 AM

Side effects of Ipilimumab, also known (4)

ohm20

07/23/2025 4:01:10 AM

Ipilimumab Safety Profile: Associated (16)

ohm20

07/23/2025 3:50:15 AM

Based on above hypothesis, It could (11)

KenChowder

07/23/2025 3:13:18 AM

MGK wrote: Based on above hypothesis, (11)

ohm20

07/23/2025 2:56:21 AM

Sorry Ohm, I'm not smart enough to (13)

USS JOHNSTON

07/22/2025 11:27:56 PM

I am also not a doctor, biloxi, so I (5)

MGK_2

07/22/2025 8:09:36 PM

I wrote (4)

biloxiblues

07/22/2025 7:37:02 PM

I am not a Doctor, but this is (4)

craigakess

07/22/2025 7:24:09 PM

Thanks for posting the response. (5)

Mr3Putt

07/22/2025 7:05:07 PM

UWS responds to you at r/Livimmune: (3)

SeeWhyDY

07/22/2025 5:49:35 PM

Am I reading this article (2)

skezan

07/22/2025 4:42:55 PM

Sorry Ohm, I'm not smart enough to (2)

ohm20

07/22/2025 3:34:27 PM

Ipilimumab is an antibody that binds to (10)

craigakess

07/22/2025 1:50:53 PM

Thanks for posting that as it is quite (6)

craigakess

07/22/2025 1:36:36 PM

Strange that it says the study was (2)

sean007

07/22/2025 1:34:19 PM

Europe Not entire (1)

Boatbuilder

07/22/2025 1:15:30 PM

Unfortunately not CYDY. (2)

docj

07/22/2025 12:28:38 PM

Good to see your post. It has been a

KenChowder

07/22/2025 11:16:35 AM

Another poster corrected me on the time (4)

Mr3Putt

07/22/2025 10:44:56 AM

The Jun 24 PR stated that the company (8)

sunray3

07/22/2025 10:36:07 AM

Well, I must admit that's a compelling (11)

Newer

Older

Recent Articles

• Belite Bio's Conditional Marketing Authorization Success for Tinlarebant
• Top Large-Cap Movers: Teradyne, Wayfair, and More Insights
• Top Stock Insights: Palantir's Surge and Pfizer's Struggles
• The Last Messages of Charlie Kirk Revealing His Fears
• Significant Stock Declines: Fiserv, eBay, and Garmin Under Pressure
• Major Moves in Tech: Earnings Reports & Market Trends Ahead
• Ford Faces Major Recall Challenges But Sees Opportunities Ahead
• Discover the Hidden Gems: Stocks Gaining Investor Interest
• OncoHost Showcases Innovative Insights in NSCLC Proteomics
• Mutuum Finance Gears Up for Exciting V1 Launch with $18M Raised
• Apple's Impressive Earnings, Bold Future Predictions Unveiled
• Fangzhou's Innovative AI Solutions Transform Chronic Care Management
• Fangzhou Innovates Chronic Disease Management with AI Solutions
• CoorsTek Bioceramics Triumphs in Legal Right to Market Hip Components
• Trump Urges Republicans to Stand Strong Against Filibuster
• Legal Justification for Military Actions Against Drug Smugglers
• GAC Group Shines in Torch Relay for National Games
• Wing Assistant: Transforming Virtual Assistance for Businesses
• Understanding Changes to SNAP: New Rules and Court Actions
• SpaceX Marks 100th Starlink Mission with Record Satellite Launches
• Mark Carney's Apology to Trump: A Diplomatic Misstep Explained
• Investors React to Elon Musk's Massive Compensation Proposal
• Why TSLA Shares Are Climbing: Insights from Gary Black
• SERES Achieves Impressive Growth and Innovative Listing Ahead
• SERES Reports 5.312 Billion RMB Net Profit, Exciting Future Ahead
• SERES Achieves Record Net Profit and Eyes Hong Kong Listing
• PL-Universe Robotics Unveils ProWhite Robot 2.0 and Advanced Hand
• PL-Universe Robotics Unveils Game-Changing ProWhite Robot 2.0
• Documenting Your Personal Injury: Insights from Brad Altman
• Essential Tips for Extending the Life of Your Driveway
• Understanding Pre-Planning Funerals: Essential Insights from Experts
• Understanding the Vital Steps in Water Damage Restoration
• Discover Falmouth: A Serene Retreat for Luxury Home Buyers
• AI Revolution: Job Risks and Investment Opportunities Ahead
• PL-Universe Robotics Unveils Innovative Robotics Solutions Today
• Essential Tips for Choosing a Trustworthy Home Care Agency
• OpenAI on Track for $100 Billion Revenue by 2027
• Exciting Travel Offers from Travelzoo for Adventurous Souls
• Understanding Today's Risky Investment Landscape
• Market Trends: The Impact of Fed's Decisions on Tech Stocks
• US Economic Activity Shows Resilience Amid Shutdown Challenges
• BlackRock Faces Challenges in Private Lending Amid Financial Unrest
• Navigating the AI Frontier: Insights from Major Earnings Reports
• Navigating Inflation Trends: What to Expect in the Future
• Navigating the Challenges of Progress and Change Today
• Navigating the Challenges of Prop Trading Successfully
• China's Vision for the Future: The Next Five-Year Plan
• Impact of the Federal Reserve's Decisions on Economic Crashes
• Top Stocks for November: Investing for Explosive Growth
• Cameco's Bold Nuclear Partnership Fuels Industry Transformation